Mivacurium chloride

Generic Medicine Info
Patients known or suspected to be homozygous for the atypical plasma cholinesterase gene.
Special Precautions
Clinically significant CV disease. Any history of greater sensitivity to the release of histamine or related mediators (e.g. asthma); assure adequate hydration and carefully monitor haemodynamic status. Obese patients. Neuromuscular diseases (e.g. myasthenia gravis and the myasthenic syndrome). Burn patients. Fluid and electrolyte abnormalities. Renal or hepatic impairment. Reduced plasma cholinesterase activity. Pregnancy and lactation.
Adverse Reactions
Cutaneous flushing, mild hypotension, moderate wheezing; tachycardia, bradycardia, phlebitis; bronchospasm, hypoxaemia; rash, inj site reaction; dizziness; prolonged drug effect; muscle spasms.
Potentially Fatal: Anaphylactoid reactions, cardiac arrhythmias.
Drug Interactions
Effects may be increasead by aminoglycosides, clindamycin, calcium-channel blockers, colistin, enflurane, halothane, isoflurane, potassium-depleting diuretics, ketamine, lidocaine, sodium colistimethate, magnesium salts, polymyxin B, procainamide, quinidine, tetracyclines, opioid analgesics, suxamethonium, vancomycin. Effect may be reduced by carbamazepine, phenytoin (chronic use), corticosteroids, calcium and theophylline.
ATC Classification
M03AC10 - mivacurium chloride ; Belongs to the class of other quaternary ammonium-containing agents used as peripherally-acting muscle relaxants.
Disclaimer: This information is independently developed by CIMS based on mivacurium chloride from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in